FACTANKER

US-Listed Biological Products, (No Diagnostic Substances) — EBITDA Margin Percentiles, FY 2025

Population: 44 US-listed companies (SIC 2836), fiscal year 2025; fiscal year ends 2025-06-30 to 2026-04-30.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile-473.2%
25th percentile-249.7%
Median-147.3%
75th percentile8.9%
90th percentile37.5%
Mean-179.6%
Minimum-869.9%
Maximum42.8%
Methodology & sources
EBITDA margin = (operating income + depreciation & amortization) / revenue, all values as filed; computed in SQL per company, then percentiles. Fiscal year 2025 = fiscal years ending 2025-06-01 to 2026-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest EBITDA Margin percentiles (live) · All Biological Products, (No Diagnostic Substances) benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2836/ebitda-margin/2025